These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1280 related items for PubMed ID: 20053690

  • 1. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [Abstract] [Full Text] [Related]

  • 2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [Abstract] [Full Text] [Related]

  • 3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 4. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N, Ferreira E, Louro D, ARSIP Participants, Caniça M.
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [Abstract] [Full Text] [Related]

  • 5. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
    Onnberg A, Mölling P, Zimmermann J, Söderquist B.
    APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
    [Abstract] [Full Text] [Related]

  • 6. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.
    Severin JA, Lestari ES, Kloezen W, Lemmens-den Toom N, Mertaniasih NM, Kuntaman K, Purwanta M, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, “Antimicrobial Resistance in Indonesia, Prevalence and Prevention” (AMRIN) study group.
    Trop Med Int Health; 2012 Apr; 17(4):455-61. PubMed ID: 22248076
    [Abstract] [Full Text] [Related]

  • 7. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005.
    Elhani D, Bakir L, Aouni M, Passet V, Arlet G, Brisse S, Weill FX.
    Clin Microbiol Infect; 2010 Feb; 16(2):157-64. PubMed ID: 19769601
    [Abstract] [Full Text] [Related]

  • 8. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, Milch H, Füzi M.
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [Abstract] [Full Text] [Related]

  • 9. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH.
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [Abstract] [Full Text] [Related]

  • 10. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM, Shahid M, Evans JT, Hawkey PM.
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [Abstract] [Full Text] [Related]

  • 11. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, Jalava J, Tarkka E, Vaara M, Vuopio-Varkila J.
    Clin Microbiol Infect; 2010 Aug; 16(8):1158-61. PubMed ID: 20670290
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The DiversiLab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
    Brolund A, Hæggman S, Edquist PJ, Gezelius L, Olsson-Liljequist B, Wisell KT, Giske CG.
    J Microbiol Methods; 2010 Nov; 83(2):224-30. PubMed ID: 20849889
    [Abstract] [Full Text] [Related]

  • 16. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 17. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.
    J Antimicrob Chemother; 2010 Apr 10; 65(4):651-60. PubMed ID: 20118165
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
    Bagattini M, Crivaro V, Di Popolo A, Gentile F, Scarcella A, Triassi M, Villari P, Zarrilli R.
    J Antimicrob Chemother; 2006 May 10; 57(5):979-82. PubMed ID: 16531430
    [Abstract] [Full Text] [Related]

  • 19. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2007 Nov 10; 51(11):4015-21. PubMed ID: 17724160
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N, Nunthapisud P, Tirawatanapong T, Dansuputra M.
    J Med Assoc Thai; 2011 Dec 10; 94(12):1504-12. PubMed ID: 22295740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.